EGRP Cancer Epidemiology News
March 2024
- AACR 2024 Sessions for Epidemiologists
- Funding Opportunities
- Grants Policy Announcements
- Requests for Information
- Training Opportunities
- Research Resources
- News, Blog Posts, and Podcasts
AACR 2024 Sessions for Epidemiologists
The 2024 American Association for Cancer Research (AACR) Annual Meeting is taking place in San Diego, California, April 5-10, 2024. To help attendees, the Epidemiology and Genomics Research Program (EGRP) has assembled a list of selected presentations by National Cancer Institute (NCI) staff that highlight important resources and topics in cancer epidemiology and genomics, funding opportunities, and grantsmanship. If you are attending the Annual Meeting this year, remember to add these sessions to your AACR Annual Meeting 2024 itinerary.
Sessions of Interest
View the list below or visit the AACR Annual Meeting website to see lists of NIH/NCI-sponsored sessions and population sciences presentations that may be of interest.
Meet-the-Expert Sessions
NCI staff will be available at the NCI exhibit booth (#1319) during exhibit hours to answer questions about NCI programs, resources, training, and funding opportunities.
In addition, the exhibit booth will host presentations from NCI scientific staff on specific topics, including the following:
- On April 8, 2:00-3:00 p.m., Danielle Daee, PhD, Joe Flores-Toro, PhD, and Adam Resnick, PhD, will speak about pediatric data resources available from NCI and NIH.
- On April 9, 12:30-1:00 p.m. PT, Leah E. Mechanic, PhD will speak about the Participant Engagement and Cancer Genome Sequencing (PE-CGS) Network and how it relates to the National Cancer Plan priorities of Engaging Every Person, Health Equity, and Maximizing Data Utility.
If you would like to meet in person with any EGRP staff attending the meeting, please contact them ahead of time:
- Danielle Daee, PhD (Genomic Epidemiology Branch)
- Rao L. Divi, PhD (Methods and Technologies Branch)
- Naoko Ishibe, ScD (Environmental Epidemiology Branch)
- Leah E. Mechanic, PhD, MPH (Genomic Epidemiology Branch)
- Stefanie A. Nelson, PhD (Genomic Epidemiology Branch)
- Sonia Rosenfield, PhD (Office of the Associate Director)
- Pothur R. Srinivas, PhD, MPH (Office of the Associate Director)
The NCI Division of Cancer Control and Population Sciences (DCCPS) has also prepared a sampling of key documents and information for attendees at this year’s AACR Annual Meeting: cancercontrol.cancer.gov/aacr. For information on activities at the NCI Exhibit Booth and sessions featuring NCI staff and leaders, visit https://www.cancer.gov/news-events/events/conferences/aacr-2024.
Funding Opportunities
- RFA-AG-25-002, Consortium for Palliative Care Research Across the Lifespan (U54, Clinical Trial Optional)
- RFA-OD-24-012, Predoctoral Training in Advanced Data Analytics for Behavioral and Social Sciences Research – Institutional Research Training Program (T32)
- RFA-OD-24-013, Building Interdisciplinary Research Careers in Women's Health (K12, Clinical Trial Optional)
- OTA-24-005, NIH Common Fund Data Ecosystem Cloud Workspace Implementation Center (OT2)
- PAR-24-109, Long-Term Effects of Disasters on Healthcare Systems in Populations with Health Disparities (R01, Clinical Trial Optional)
- PAR-24-144, Support for Research Excellence Award (R16, Clinical Trial Not Allowed)
- PAR-24-145, Support for Research Excellence First Independent Research Award (R16, Clinical Trial Not Allowed)
- PA-23-189, Research Supplements to Promote Diversity in Health-Related Research (Admin Supp, Clinical Trial Not Allowed)
- PA-24-141, NIH Support for Conferences and Scientific Meetings (Parent R13, Clinical Trial Not Allowed)
- NOT-CA-24-030, Notice of Special Interest (NOSI): Administrative Supplements for Contemporary Modifiable Exposures and Cancer Across the Life Course and Cancer Control Continuum
- NOT-OD-24-031, NOSI: Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Clinical Trial Optional)
- NOT-CA-23-037, NOSI: Technology Development for Cancer Control and Population Science Research
- NOT-CA-24-032, NOSI: Administrative Supplements to Understand Effects of Within-group Heterogeneity on Cancer Control Outcomes in Underrepresented Populations
- NOT-CA-24-031, NOSI: Validation of Digital Health and Artificial Intelligence/Machine Learning Tools for Improved Assessment in Biomedical and Behavioral Research
- NOT-CA-24-035, NOSI: Administrative Supplements for Assessing and Enhancing Survivorship Care
- NOT-CA-24-037, NOSI: Epidemiologic Studies to Assess the Impact of Incretin Mimetics on New and Recurrent Cancer Risk
- NOT-RM-24-003, NOSI: Research Supplements to Promote Workforce Diversity and Enhance Utility and Use of Common Fund Datasets
- NOT-CA-24-033, NOSI: Telehealth Research in Cancer Care
- NOT-OD-24-058, NOSI: Developing and Testing Multi-level Physical Activity Interventions to Improve Health and Well-Being
Grants Policy Announcements
- NOT-OD-24-069, Update Related to the Issuance of the FY 2024 NIH Grants Policy Statement
- NOT-OD-24-067, Guidance for Videos Submitted as NIH Application Materials
- NOT-OD-24-072, NIH Sexual and Gender Minority Research Office Announces Regional Workshop on Sexual and Gender Minority-Related Health Research
Requests for Information
Training Opportunities
Research Resources
News, Blog Posts, and Podcasts
- Cancer HealthCast: This Unique Network Closes Research Gaps in Cancer Genomics
- For Childhood Cancer Survivors, Inherited Genetic Factors Influence Risk of Cancers Later in Life
- Cancer Grand Challenges Selects Five New Global, Interdisciplinary Teams to Take on Four Challenges
- The President’s Cancer Panel Initial Assessment of the National Cancer Plan
- A Brief Message for Bottom Line Readers, from NCI Director Dr. Rathmell
- NIH to Address Dwindling Clinical Trial Patient Enrollment with Centralized Staffing Support
- NIH Office of Disease Prevention Strategic Plan for Fiscal Years 2024-2028
- How Implementing a 2022 Law Is Helping Us Ensure Safe and Respectful Workplaces
- How Many Researchers: The FY 2023 Cumulative Investigator Rate
- FY 2023 By the Numbers: Extramural Grant Investments in Research
Stay Connected
Subscribe for Updates
Subscribe
You can subscribe and unsubscribe at any time by entering your email address and selecting your preferences on the page that follows.
Need Help?
EGRP staff can answer questions on grant funding, policies, and research resources. If you do not know who to contact we will do our best to connect you with someone who can help you.
Email Us(240) 276-6730